
|Articles|January 1, 2005
It's crunch time: Tips to make up for lost dollars
The year 2005 will portend a significant decrease in income for nearly every American urologist. Most will be impacted by Medicare's slashing the reimbursement for LHRH agonists and certain other drugs administered in the office. Solo practitioners can anticipate annual losses of income in the thousands of dollars, and larger group practices can expect over a $1 million shortfall this year.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves lutetium Lu 177 vipivotide tetraxetan for PSMA-positive mHSPC
2
Individualizing androgen pathway therapy in mCSPC
3
Testosterone deficiency: FAQs from the AUA guideline
4
Large registry study reports durable 10-year outcomes with focal therapy for prostate cancer
5












